National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

indium In 111 monoclonal antibody BrE-3
A humanized monoclonal antibody conjugated to the imaging radioisotope (indium-111). This radioimmunoconjugate binds to the breast epithelial mucin antigen, which is found primarily on breast cancer cells, permitting radioimmmuno-localization of mucin-positive tumor cells and an estimate of radiation dosimetry prior to administration of cytotoxic radiotherapy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:In 111 monoclonal antibody BrE-3
Abbreviation:In 111 MOAB BrE-3



Previous:indium I 111 bevacizumab, indium I 111 chimeric monoclonal antibody G250, indium In 111 chimeric monoclonal antibody 806, indium In 111 CHX-A DTPA trastuzumab, indium In 111 ibritumomab tiuxetan
Next:indium In 111 monoclonal antibody huPAM4, indium In 111 pentetate, indium In 111-CMD-193, indium In 111-labeled autologous peripheral blood mononuclear cells, indium In 111-labeled autologous polymorphonuclear leukocytes

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov